Transport

GV participated in tech apprenticeship platform Multiverse’s $220m series D round while Amgen, UCB, UPMC and Takeda helped genetics disease drug developer Code Biotherapeutics raise $75m.

GCV has spoken to several corporate and VC investors about the recent hit to Australia's startup scene following a post-lockdown deal surge.

It pays to invest in these companies. Research shows they are less likely to fail and will attract two to three times more investment.

The number of corporate-backed deals dropped by 13% year-on-year in May, the first clear sign that the market pullback is having an impact.

SoftBank Latin America Fund is among the investors in payment technology provider Kushki’s $186m series B round while Maruho co-led inflammatory disease drug developer Upstream's $200m series A.

Envision Group’s Envision Digital subsidiary raised $210m in series A funding while Sarnoff Corporation’s Intuity Medical spinoff will shut down at the start of July.

SAIC Motor and GAC Group took part in industrial software developer UniVista Industrial's $164m pre-series A round while multiple corporates helped biotech incubator Doma Biopharmaceutical raise $142m.

With a new $500m vehicle, Binance became the latest crypto company to amass huge piles of capital to build up the industry.

Biren Technology helped provide $120m for CPU producer HJ Micro while ArcelorMittal is set to invest $100m a year through its XCarb Innovation Fund and Accelerator Programme.

Researchers or investors could face jail terms if they work with someone they “ought to know” is under the direction of a foreign power.

SoftBank Vision Fund 2 and Porsche were among the investors in a late-stage round indicating the need for additional cashflow as new vehicle developers see the public markets shut off.